Pacira Biosciences, Inc. (PCRX)
25.21
+0.44
(+1.78%)
USD |
NASDAQ |
Dec 10, 15:18
Pacira Biosciences EPS Diluted (Quarterly): 0.1222 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Hologic, Inc. | 0.8298 |
| CorMedix, Inc. | 1.259 |
| ADMA Biologics, Inc. | 0.1489 |
| Atara Biotherapeutics, Inc. | -0.3172 |
| AnaptysBio, Inc. | 0.5208 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | 5.432M |
| Revenue (Quarterly) | 179.52M |
| Total Expenses (Quarterly) | 174.08M |
| Enterprise Value | 1.245B |
| Gross Profit Margin (Quarterly) | 72.93% |
| Profit Margin (Quarterly) | 3.03% |
| Earnings Yield | 1.77% |
| Operating Earnings Yield | 5.13% |
| Normalized Earnings Yield | 2.937 |